These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5593694)

  • 21. [High hematocrit. A review over the most important forms of erythrocytosis].
    Freund LG; Hasselbalch HC; Berild D
    Ugeskr Laeger; 1984 Jul; 146(27):2001-4. PubMed ID: 6515781
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of testosterone on erythropoiesis of WW-v mice.
    Fried W; Rishpon-Meyerstein N; Gurney CW
    J Lab Clin Med; 1967 Nov; 70(5):813-9. PubMed ID: 6055765
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of nCPAP therapy on the blood picture in patients with obstructive sleep apnea].
    Sanner B; Konermann M; Doberauer C; Laschewski F; Kreuzer I
    Pneumologie; 1995 Jul; 49(7):413-7. PubMed ID: 7675756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the behavior of erythropoietin-sensitive cells in the mouse during recovery from 200 roentgens of whole-body irradiation.
    Schooley JC; Hayes JM; Cantor LN; Havens VW
    Radiat Res; 1967 Dec; 32(4):875-83. PubMed ID: 6066594
    [No Abstract]   [Full Text] [Related]  

  • 25. [Fatal pancytopenia after treatment of polycythemia vera with myleran].
    FRICK PG
    Schweiz Med Wochenschr; 1960 Sep; 90():1035-7. PubMed ID: 13701897
    [No Abstract]   [Full Text] [Related]  

  • 26. [The vascular manifestations of polycythemia].
    Viala JJ; Brun F; Chataing B
    Lyon Med; 1968 Jun; 219(23):1907-12 passim. PubMed ID: 5670634
    [No Abstract]   [Full Text] [Related]  

  • 27. Enalapril: safe and effective therapy for posttransplant erythrocytosis.
    Gaston RS; Julian BA; Barker CV; Diethelm AG; Curtis JJ
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1029-31. PubMed ID: 8442029
    [No Abstract]   [Full Text] [Related]  

  • 28. New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
    Sauron C; Berthoux P; Berthoux F; Alamartine E; Diab N; Broyet C; Hacini J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1032-3. PubMed ID: 8382847
    [No Abstract]   [Full Text] [Related]  

  • 29. Correction of posttransplant erythrocytosis with enalapril.
    Rell K; Koziak K; Jarzyo I; Lao M; Gaciong Z
    Transplantation; 1994 Apr; 57(7):1059-63. PubMed ID: 8165703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HUMORAL REGULATION OF ERYTHROPOIESIS. XI. THE PATTERN OF RESPONSE TO SPECIFIC THERAPY IN IRON DEFICIENCY ANEMIA.
    MOORES RR; STOHLMAN F; BRECHER G
    Blood; 1963 Sep; 22():286-94. PubMed ID: 14056868
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bone marrow aplasia consecutive to myleran therapy of chronic myeloid leukemia].
    KHURGIN MI; KHASANOVA RI
    Probl Gematol Pereliv Krovi; 1959 Jan; 4(1):52-3. PubMed ID: 13645532
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pregnancy during busulfan therapy of chronic granulocytic leukemia].
    Szentcsíki M; Brenner F; Balogh C; Hites L
    Orv Hetil; 1982 May; 123(21):1307-8. PubMed ID: 6955735
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of graded, single doses of busulfan on murine erythropoiesis.
    Boggs DR; Boggs SS
    Proc Soc Exp Biol Med; 1980 Feb; 163(2):181-6. PubMed ID: 7360747
    [No Abstract]   [Full Text] [Related]  

  • 34. Familial polycythemia in cattle.
    Tennant B; Asbury AC; Laben RC; Richards WP; Kaneko JJ; Cupps PT
    J Am Vet Med Assoc; 1967 Jun; 150(12):1493-509. PubMed ID: 6067913
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
    Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
    Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron metabolism in familial polycythemia of Jersey calves.
    Kaneko JJ; Zinkl J; Tennant BC; Mattheeuws DR
    Am J Vet Res; 1968 May; 29(5):949-52. PubMed ID: 5689893
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is Myleran (busulfan) a leukemogenic substance?].
    Hunstein W
    Schweiz Med Wochenschr; 1965 Oct; 95(43):1437-9. PubMed ID: 5880927
    [No Abstract]   [Full Text] [Related]  

  • 38. Neonatal polycythemia: II. Definition related to time of sampling.
    Shohat M; Reisner SH; Mimouni F; Merlob P
    Pediatrics; 1984 Jan; 73(1):11-3. PubMed ID: 6691031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Busulfan-containing pre-transplant regimens for the treatment of solid tumors.
    Ghalie R; Reynolds J; Valentino LA; Manson S; Korenblit AD; Feingold JM; Adler SS; Pruett J; Kaizer H
    Bone Marrow Transplant; 1994 Sep; 14(3):437-42. PubMed ID: 7994269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of captopril in the treatment of erythrocytosis after renal transplantation.
    Suh BY; Suh JD; Kwun KB
    Transplant Proc; 1996 Jun; 28(3):1557-8. PubMed ID: 8658784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.